Maria Leandro: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "|date=2018|" to " | date = 2018 | ") |
Notjusttired (talk | contribs) m (Text replacement - "|date=" to " | date = ") |
||
| Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
{{NeedsImage}} | {{NeedsImage}} | ||
'''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=https://www.uclh.nhs.uk/OurServices/Consultants/Pages/DrMariaLeandro.aspx|title=Dr Maria Leandro - UCL Hospitals|last = |first = |date=|website=|archive-url=|archive-date=|url-status=|access-date=}}</ref> | '''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=https://www.uclh.nhs.uk/OurServices/Consultants/Pages/DrMariaLeandro.aspx|title=Dr Maria Leandro - UCL Hospitals|last = |first = | date = |website=|archive-url=|archive-date=|url-status=|access-date=}}</ref> | ||
== Notable studies == | == Notable studies == | ||
Revision as of 12:02, October 26, 2022
 | This article is a stub. |
Maria Leandro, MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, United Kingdom. Her research interests are in inflammatory arthritis, rheumatoid arthritis, B cell directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.[1]
Notable studies[edit | edit source]
- 2016, Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study[2] (Full Text)
- 2018, CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[3] (Full Text)
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Dr Maria Leandro - UCL Hospitals".
- ↑ Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749
- ↑ Mensah, Fane F. K.; Armstrong, Christopher W.; Reddy, Venkat; Bansal, Amolak S.; Berkovitz, Saul; Leandro, Maria J.; Cambridge, Geraldine (2018). "CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02421. ISSN 1664-3224.
